Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AURORA study: 5-ALA photodynamic diagnosis for bladder urothelial cancer
jRCT1091220081Completed
- Sponsor
- SBI Pharmaceuticals
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of 5-aminolevulinic acid in transitional cell carcinoma of the bladder (TCC) (2 arms), sponsored by SBI Pharmaceuticals. Primary endpoint: Sensitivity. Started Jan 2012; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
transitional cell carcinoma of the bladder (TCC)
Beyond the preview
Go deeper on jRCT1091220081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1091220081.